Cholecystokinin A Receptor (CCKAR) Antibody (FITC)

Este producto es parte de CCK - Cholecystokinin A Receptor
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Cholecystokinin A Receptor (CCKAR) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx335092

Description

CCKAR Antibody (FITC) is a Rabbit Polyclonal against CCKAR.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Cholecystokinin A Receptor (CCKAR)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P32238
Gene ID
886
Alias
CCKAR,CCK-1R,CCK-A,CCK1-R,CCK1R,CCKRA,CCK1-R,cholecystokinin receptor type A,cholecystokinin-1 receptor
Background
Antibody anti-CCKAR
Status
RUO

Descripción

CCKAR is a G protein-coupled receptor (GPCR) predominantly expressed in the gastrointestinal tract, pancreas, and brain, where it binds the peptide hormone cholecystokinin (CCK) with high affinity. It regulates digestive processes by stimulating gallbladder contraction, pancreatic enzyme secretion, and gastric motility. In the brain, CCKAR is involved in satiety signaling, regulating appetite and feeding behavior by modulating neuronal pathways in the hypothalamus and brainstem. Its activation triggers downstream signaling pathways such as phospholipase C (PLC), calcium mobilization, and protein kinase C (PKC), leading to cellular responses like smooth muscle contraction and enzyme secretion. CCKAR is implicated in metabolic disorders, including obesity, where dysregulated signaling contributes to appetite dysregulation and energy imbalance. It also plays a role in anxiety and mood disorders, as CCK signaling interacts with neurotransmitter systems like dopamine and serotonin. In cancer, CCKAR overexpression has been observed in pancreatic and gastrointestinal cancers, where it enhances cell proliferation and survival. Pharmacological targeting of CCKAR is being explored for obesity, gastrointestinal disorders, and certain cancers. Overall, CCKAR is essential for gastrointestinal function, appetite regulation, and metabolic homeostasis.

Related Products

EH2772

Human CCKAR(Cholecystokinin A Receptor) ELISA Kit

Ver Producto
EM0907

Mouse CCKAR(Cholecystokinin A Receptor) ELISA Kit

Ver Producto
ER0809

Rat CCKAR(Cholecystokinin A Receptor) ELISA Kit

Ver Producto